Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,017,755
-
Share change
-
-271,300
-
Total reported value
-
$19,163,764
-
Price per share
-
$3.82
-
Number of holders
-
22
-
Value change
-
-$1,154,855
-
Number of buys
-
13
-
Number of sells
-
15
Institutional Holders of InflaRx N.V. - COM (IFRX) as of Q1 2020
As of 31 Mar 2020,
InflaRx N.V. - COM (IFRX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,017,755 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, FNY Investment Advisers, LLC, Ikarian Capital, LLC, Eversept Partners, LP, GOLDMAN SACHS GROUP INC, Birchview Capital, LP, Point72 Asset Management, L.P., and MORGAN STANLEY.
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.